title: [Pharmacokinetics and changes in the physical properties of blood and urine after administration of dextran 60000].
abstract: A study was carried out to assess the changes induced by an infusion of dextran, molecular weight 60,000 daltons, in blood and urine. Plasma and urine dextran and serum protein concentrations, haematocrit, blood and urine viscosities, and blood oncotic pressure were measured in 10 consecutive male patients. Fifteen min after administration of 20 ml dextran 1000 (Promit), they were each given 500 ml (30 g) dextran 60 (Hemodex) over 30 min for plasma volume expansion. The measurements were carried out at the end of the infusion, and then at regular intervals over a 48 h period. The highest dextran blood concentrations were found at the end of the infusion, decreasing thereafter with a distribution half-life of 1.83 +/- 0.64 h, and an elimination half-life of 25.5 +/- 7.6 h. Haematocrit values decreased by 12%, and serum protein concentrations by 9.5%, after the end of the infusion. These changes remained significant for 9 h; they were probably due to the dilution effect of 500 ml of dextran. Colloid osmotic pressure was not significantly altered (20.7 +/- 4.7 mmHg vs. 23.1 +/- 5.1 mmHg 48 h after the end of the infusion). The colloid osmotic pressure due to dextran 60 compensated for the fall in protein concentration. A decrease in blood viscosity was found at different shear rates, despite dextran 60 being highly viscous. This could also be explained by a dilution effect. The highest degree of urinary excretion occurred 30 min after the end of the infusion, and lasted for 3 h. Forty-five percent of the total dextran dose had been excreted by the 48th hour.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Département d'Anesthésie-Réanimation A, Hôpital Lapeyronie, Montpellier.
authors.forename: J
authors.initials: J
authors.lastname: Kienlen
authors.forename: J C
authors.initials: JC
authors.lastname: Mathieu-Daudé
authors.forename: D
authors.initials: D
authors.lastname: Passeron
authors.forename: A
authors.initials: A
authors.lastname: Dellord
authors.forename: F
authors.initials: F
authors.lastname: d'Athis
authors.forename: J
authors.initials: J
authors.lastname: du Cailar
mesh_terms: D000328:Adult; D001798:Blood Proteins / Q000032:analysis; D001809:Blood Viscosity / Q000187:drug effects*; D003911:Dextrans / Q000097:blood / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000652:urine; D006400:Hematocrit; D006438:Hemodilution / Q000379:methods; D006801:Humans; D008297:Male; D008657:Metabolic Clearance Rate; D014556:Urine / Q000737:chemistry*
chemical_list: D001798:Blood Proteins; D003911:Dextrans
vernacular_title: Pharmacocinétique et modifications des propriétés physiques du sang et des urines apès administration d'un dextran 60,000.